Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: Results of a phase II trial

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 5, 2011, Pages 1343-1349

  Bral, Samuel ^a   Gevaert, Thierry ^a   Linthout, Nadine ^a   Versmessen, Harijati ^a   Collen, Christine ^a   Engels, Benedikt ^a   Verdries, Douwe ^a   Everaert, Hendrik ^a   Christian, Nicolas ^a   De Ridder, Mark ^a   Storme, Guy ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Gating; Image guided radiotherapy; Non small cell lung cancer; Phase II; Stereotactic body radiotherapy

Indexed keywords

GATING; IMAGE GUIDED RADIOTHERAPY; NON SMALL CELL LUNG CANCER; PHASE II; STEREOTACTIC BODY RADIOTHERAPY;

BIOLOGICAL ORGANS; DISEASES; DRUG PRODUCTS; ESTIMATION; ONCOLOGY; PATIENT MONITORING; TOXICITY; TUMORS;

RADIOTHERAPY;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CONTROL; CANCER SURVIVAL; CLINICAL ARTICLE; COUGHING; DISEASE SEVERITY; DYSPHAGIA; DYSPNEA; FATIGUE; FEMALE; FEVER; HEADACHE; HEARTBURN; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MALE; MORBIDITY; MORTALITY; NAUSEA; OUTCOME ASSESSMENT; PAIN; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; PULMONARY VALVE STENOSIS; RADIATION DOSE FRACTIONATION; RISK FACTOR; SCORING SYSTEM; SKIN DISEASE; STEREOTACTIC BODY RADIATION THERAPY; TUMOR VOLUME;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 79960100093     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.04.056     Document Type: Article

References (36)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. C.I. Henschke, D.F. Yankelevitz, and D.M. Libby Survival of patients with stage I lung cancer detected on CT screening N Engl J Med 355 2006 1763 1771 (Pubitemid 44631359)
3. W.J. Scott, J. Howington, and S. Feigenberg Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 2007 234S 242S (Pubitemid 47502810)
4. N.P. Rowell, and C.J. Williams Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): A systematic review Thorax 56 2001 628 638 (Pubitemid 32706145)
5. P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
6. Y. Nagata, K. Takayama, and Y. Matsuo Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 2005 1427 1431 (Pubitemid 41628038)
7. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
8. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839 (Pubitemid 46630909)
9. R.C. McGarry, L. Papiez, and M. Williams Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study Int J Radiat Oncol Biol Phys 63 2005 1010 1015 (Pubitemid 41505277)
10. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
11. F.J. Lagerwaard, C.J. Haasbeek, and E.F. Smit Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
12. S. Bral, H. Van Parijs, and G. Soete A feasibility study of image-guided hypofractionated conformal arc therapy for inoperable patients with localized non-small cell lung cancer Radiother Oncol 84 2007 252 256 (Pubitemid 47362402)
13. R. Onimaru, M. Fujino, and K. Yamazaki Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy Int J Radiat Oncol Biol Phys 70 2008 374 381
14. N. Linthout, S. Bral, and I. Van de Vondel Treatment delivery time optimization of respiratory gated radiation therapy by application of audio-visual feedback Radiother Oncol 91 2009 330 335
15. I. Paddick, and B. Lippitz A simple dose gradient measurement tool to complement the conformity index J Neurosurg 105 Suppl 2006 194 201
16. I. Paddick A simple scoring ratio to index the conformity of radiosurgical treatment plans: Technical note J Neurosurg 93 Suppl 3 2000 219 222 (Pubitemid 32799579)
17. D. Verellen, G. Soete, and N. Linthout Optimal control of set-up margins and internal margins for intra- and extracranial radiotherapy using stereoscopic kilovoltage imaging Cancer Radiother 10 2006 235 244 (Pubitemid 44486836)
18. D. Verellen, G. Soete, and N. Linthout Quality assurance of a system for improved target localization and patient set-up that combines real-time infrared tracking and stereoscopic X-ray imaging Radiother Oncol 67 2003 129 141 (Pubitemid 36570449)
19. L. Decoster, D. Schallier, and H. Everaert Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC) Lung Cancer 62 2008 55 61
20. S. Bral, M. Duchateau, and R.M. De Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC Radiother Oncol 91 2009 438 442
21. J. Bryant, and R. Day Incorporating toxicity considerations into the design of two-stage phase II clinical trials Biometrics 51 1995 1372 1383 (Pubitemid 26030182)
22. C. Park, L. Papiez, and S. Zhang Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy Int J Radiat Oncol Biol Phys 70 2008 847 852 (Pubitemid 351199730)
23. R. Timmerman, R. Paulus, and J. Galvin Toxicity analysis of RTOG 0236 using SBRT to treat medically inoperable early stage lung cancer patients. I nt J Radiat Oncol Biol Phys 69 2007 S86
24. R.W. Underberg, F.J. Lagerwaard, and B.J. Slotman Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: An analysis of 4DCT datasets Int J Radiat Oncol Biol Phys 62 2005 554 560 (Pubitemid 40704475)
25. R.W. Underberg, F.J. Lagerwaard, and J.P. Cuijpers Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer Int J Radiat Oncol Biol Phys 60 2004 1283 1290 (Pubitemid 39440815)
26. S.L. Kwa, J.V. Lebesque, and J.C. Theuws Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients Int J Radiat Oncol Biol Phys 42 1998 1 9 (Pubitemid 28435589)
27. M.V. Graham, J.A. Purdy, and B. Emami Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 1999 323 329 (Pubitemid 29408545)
28. E.D. Yorke, A. Jackson, and K.E. Rosenzweig Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study Int J Radiat Oncol Biol Phys 63 2005 672 682 (Pubitemid 41400051)
29. I. Kyas, H. Hof, and J. Debus Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer Int J Radiat Oncol Biol Phys 67 2007 768 774 (Pubitemid 46215862)
30. H. Yamashita, K. Nakagawa, and N. Nakamura Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors Radiat Oncol 2 2007 21
31. M. Fujino, H. Shirato, and H. Onishi Characteristics of patients who developed radiation pneumonitis requiring steroid therapy after stereotactic irradiation for lung tumors Cancer J 12 2006 41 46
32. M. Paludan, H.A. Traberg, and J. Petersen Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency? Acta Oncol 45 2006 818 822 (Pubitemid 44423127)
33. C.W. Hurkmans, J.P. Cuijpers, and F.J. Lagerwaard Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: Report from the Quality Assurance Working Party of the randomised phase III ROSEL study Radiat Oncol 4 2009 1
34. R. Rami-Porta, D. Ball, and J. Crowley The IASLC Lung Cancer Staging Project: Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer J Thorac Oncol 2 2007 593 602 (Pubitemid 47171780)
35. M. Hoyer, H. Roed, and A. Traberg Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 66 2006 S128 S135
36. D.J. Hoopes, M. Tann, and J.W. Fletcher FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer Lung Cancer 56 2007 229 234 (Pubitemid 46590486)